Bicycle Therapeutics (BCYC)
13.24
0.20 (1.53%)
At close: Jan 28, 2025, 2:30 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| PE Ratio | -3.56 | -7.79 | -22.83 | -6.74 | -3.4 | -7.3 | -9.81 | -15.72 |
| PS Ratio | 23.85 | 60.70 | 130.42 | 33.08 | 7.55 | 22.35 | 77.44 | n/a |
| PB Ratio | 1.73 | 3.24 | 4.41 | 3.60 | 1.12 | -2.28 | -3.38 | 26.47 |
| P/FCF Ratio | -10.12 | -8.35 | -90.67 | -18.1 | -3.45 | -5.85 | -63.1 | -18.45 |
| P/OCF Ratio | -10.61 | -10.2 | -103.12 | -19.32 | -3.64 | -6.12 | -112.74 | -18.85 |
| OCF/S Ratio | -2.25 | -5.95 | -1.26 | -1.71 | -2.07 | -3.65 | -0.69 | n/a |
| Debt / Equity Ratio | 0.12 | 0.16 | 0.13 | 0.17 | 0.02 | n/a | n/a | n/a |
| Quick Ratio | 8.08 | 6.92 | 12.65 | 6.73 | 11.81 | 8.60 | 7.57 | 2.96 |
| Current Ratio | 8.08 | 6.92 | 12.65 | 6.73 | 11.81 | 8.60 | 7.57 | 2.96 |
| Asset Turnover | 0.05 | 0.04 | 0.02 | 0.06 | 0.13 | 0.09 | 0.03 | n/a |
| Interest Coverage | -58.21 | -34.88 | -21.99 | -113.7 | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.49 | -0.42 | -0.19 | -0.53 | -0.33 | 0.31 | 0.34 | -1.68 |
| Return on Assets (ROA) | -0.3 | -0.27 | -0.14 | -0.32 | -0.28 | -0.27 | -0.22 | -1.14 |
| Return on Capital (ROIC) | -0.36 | -0.33 | -0.15 | -0.38 | -0.26 | -0.3 | -0.25 | -1.68 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 76.03% | 74.51% | -283.69% | -219.05% | -85.06% | -190.93% | -476.02% | n/a |
| Net Profit Margin | -669.72% | -779.35% | -571.25% | -490.95% | -221.78% | -306.14% | -789.27% | n/a |
| Pretax Profit Margin | -664.32% | -789.88% | -585.47% | -497.92% | -223.62% | -311.69% | -790.39% | n/a |
| Operating Profit Margin | -704.13% | -806.56% | -560.98% | -500.1% | -190.56% | -304.74% | -787.04% | n/a |
| FCF Margin | -235.61% | -726.67% | -143.83% | -182.76% | -218.59% | -382.06% | -122.72% | n/a |
| EBITDA Margin | -679.86% | -781.06% | -547.84% | -484.98% | -217.56% | -301.2% | -770.92% | n/a |